These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34000149)

  • 1. Potential Drug-Drug Interactions Between Interleukin-6 Inhibitors and Pharmacologic Agents for Opioid Use Disorder.
    Kow CS; Hasan SS
    Prim Care Companion CNS Disord; 2021 Feb; 23(1):. PubMed ID: 34000149
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
    [No Abstract]   [Full Text] [Related]  

  • 3. Responding to Unsafe Opioid Use: Abandon the Drug, Not the Patient.
    Tobin DG; Holt SR; Doolittle BR
    J Gen Intern Med; 2021 Mar; 36(3):790-791. PubMed ID: 33037590
    [No Abstract]   [Full Text] [Related]  

  • 4. Public interest in medication-assisted treatment for opioid used disorder in the United States.
    Niforatos JD; Zheutlin AR; Pescatore RM; Raja AS
    Am J Emerg Med; 2019 Oct; 37(10):1983-1985. PubMed ID: 31056384
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of New Analgesics: An Answer to Opioid Epidemic.
    Yaksh TL; Hunt MA; Dos Santos GG
    Trends Pharmacol Sci; 2018 Dec; 39(12):1000-1002. PubMed ID: 30454767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective.
    Mansuri Z; Shah B; Trivedi C; Beg U; Patel H; Jolly T
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32628368
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for opioid Use disorder.
    Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
    [No Abstract]   [Full Text] [Related]  

  • 8. How FDA Failures Contributed to the Opioid Crisis.
    Kolodny A
    AMA J Ethics; 2020 Aug; 22(1):E743-750. PubMed ID: 32880367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse-Deterrent Opioid Formulations #329.
    O'Neill R; Lor K; Pruskowski J
    J Palliat Med; 2017 Jun; 20(6):676-678. PubMed ID: 28333577
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-Drug Interactions Associated with Introduction of Oxycodone for Management of Cancer-Related Pain in Hospitalized Patients.
    Takagi S; Yasu T; Kuroki A; Shirota M
    J Palliat Med; 2021 Sep; 24(9):1272-1273. PubMed ID: 34469226
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Opioid Use Disorder Treatment: An Overview.
    Salmond S; Allread V; Marsh R
    Orthop Nurs; 2019; 38(2):118-126. PubMed ID: 30789485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicines for Patients After an Opioid Overdose.
    Ann Intern Med; 2018 Aug; 169(3):. PubMed ID: 29913484
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison table: some drugs for maintenance treatment of opioid use disorder.
    Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceuticals, Opioid Use, Health Spending, And More.
    Weil AR
    Health Aff (Millwood); 2024 Jan; 43(1):5. PubMed ID: 38190598
    [No Abstract]   [Full Text] [Related]  

  • 15. Tapentadol is the least common opioid found in admission urine drug-test results at an intensive outpatient opioid-use disorder treat-ment program in Ohio: A brief report.
    Rzetelny A; Meske D; Patel P; Passik S
    J Opioid Manag; 2021; 17(1):13-17. PubMed ID: 33735424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
    Raheemullah A; Lembke A
    JAMA Intern Med; 2019 Mar; 179(3):427-428. PubMed ID: 30640372
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of perioperative pain management of opioid-dependent patients.
    Vadivelu N; Mitra S; Kai AM; Kodumudi G; Gritsenko K
    J Opioid Manag; 2016; 12(4):289-301. PubMed ID: 27575830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies.
    Batkis MF; Treisman GJ; Angelino AF
    AIDS Patient Care STDS; 2010 Jan; 24(1):15-22. PubMed ID: 20095910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Opioid Use Disorder Attributed to Fentanyl With High-Dose Buprenorphine: A Case Report.
    Baca-Atlas MH; Williams JB
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):83-85. PubMed ID: 33105170
    [No Abstract]   [Full Text] [Related]  

  • 20. A new abuse-deterrent opioid--Xtampza ER.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):77-8. PubMed ID: 27305067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.